![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The following two articles have been retracted by the authors for uncertainty in the integrity of some of the published data:
1: Motlekar NA, Fasano A, Wachtel MS, Youan BB. 2006. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
J Drug Target 14(5):321–329.
2: Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB. 2005.
Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
J Drug Target 13(10):573–583.